|By Business Wire||
|May 15, 2014 11:18 AM EDT||
Research and Markets (http://www.researchandmarkets.com/research/hhg4s5/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
Some of the major companies profiled in this report include Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., A. Menarini Diagnostics, F. Hoffmann-La Roche Ltd. and Siemens Healthcare.
This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing.
The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter's five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market.
The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses hemoglobin A1c testing. With respect to technologies, this study considers five testing categories, namely, immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. The above segments are analyzed on the basis of their market size (revenue) for the period 2011 to 2019 in terms of USD million, along with their growth forecast in terms of CAGR for the period 2013 to 2019, considering 2012 as the base year.
With respect to geographical distribution, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market in terms of USD million. The report further provides strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market.
The global hemoglobin A1c testing devices market is categorized into the following segments:
Hemoglobin A1cTesting Devices Market, by End-use
- Laboratory Testing Devices
- Point-of-Care (POC)Testing Devices
Hemoglobin A1cTesting Devices Market, by Technology
- Ion-Exchange High Performance Liquid Chromatography (HPLC)
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
- Others (Micro-Optical Detection Method and Capillary Electrophoresis)
For more information visit http://www.researchandmarkets.com/research/hhg4s5/hemoglobin_a1c
Sep. 29, 2016 09:45 PM EDT Reads: 3,120
Sep. 29, 2016 08:45 PM EDT Reads: 1,543
Sep. 29, 2016 08:45 PM EDT Reads: 2,203
Sep. 29, 2016 06:15 PM EDT Reads: 3,675
Sep. 29, 2016 06:00 PM EDT Reads: 1,535
Sep. 29, 2016 05:15 PM EDT Reads: 2,853
Sep. 29, 2016 05:15 PM EDT Reads: 1,581
Sep. 29, 2016 04:45 PM EDT Reads: 2,786
Sep. 29, 2016 04:45 PM EDT Reads: 3,439
Sep. 29, 2016 04:30 PM EDT Reads: 1,341
Sep. 29, 2016 04:30 PM EDT Reads: 1,957
Sep. 29, 2016 04:00 PM EDT Reads: 2,396
Sep. 29, 2016 04:00 PM EDT Reads: 478
In his session at @ThingsExpo, Kausik Sridharabalan, founder and CTO of Pulzze Systems, Inc., will focus on key challenges in building an Internet of Things solution infrastructure. He will shed light on efficient ways of defining interactions within IoT solutions, leading to cost and time reduction. He will also introduce ways to handle data and how one can develop IoT solutions that are lean, flexible and configurable, thus making IoT infrastructure agile and scalable.
Sep. 29, 2016 03:30 PM EDT Reads: 1,627
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). Download Slide Deck: ▸ Here In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discusse...
Sep. 29, 2016 03:30 PM EDT Reads: 2,552